Intensive radiation therapy added to standard cancer treatment for spread disease

This trial is testing whether stereotactic body radiotherapy (SBRT)—a form of high-dose, precisely targeted radiation—works better when added to your standard cancer treatment compared to standard treatment alone. You would be randomly assigned to receive either standard treatment alone, or standard treatment plus SBRT to all sites where your cancer has spread. The goal is to see if this combined approach helps patients live longer.

When cancer spreads to only a few sites in the body (called oligometastatic disease), doctors believe treating those specific spots aggressively might improve survival. This trial is testing whether the new radiation approach can do that better than standard care alone.